---
title: "PPI Deprescription and 30-Day Clostridioides difficile Risk: Substudy of the MedSafer Trial"
id: "medrxiv-7-effect-of-proton-pump-inhibitor-deprescription-on-the-risk-of-clostridioides"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-effect-of-proton-pump-inhibitor-deprescription-on-the-risk-of-clostridioides"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1?rss=1"
published_at: "2026-07-24T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# PPI Deprescription and 30-Day Clostridioides difficile Risk: Substudy of the MedSafer Trial
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-effect-of-proton-pump-inhibitor-deprescription-on-the-risk-of-clostridioides
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1?rss=1)
- **Published At:** 2026-07-24T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This quasi-interventional substudy analyzed the association between **proton pump inhibitor (PPI) deprescription** and 30-day **Clostridioides difficile infection (CDI)** using the MedSafer trial dataset. - The parent MedSafer trial randomized hospitalized older adults on ≥5 medications to usual care or electronic deprescribing decision support; this substudy included all trial participants regardless of randomization arm. - Patients were categorized by PPI use at hospital admission and at discharge to identify those deprescribed from home PPI and those newly started on PPI in hospital. - The analysis included 4,990 patients: 405 (8.1%) had their home PPI deprescribed and 325 (6.5%) were new PPI users by discharge. - Thirty-day CDI occurred in 32 patients (0.6%) across the cohort. - A Bayesian mixed-effect logistic regression adjusted for prespecified confounders found PPI deprescription associated with a higher probability of increased CDI odds (adjusted odds ratio [aOR] = 3.66; 95% credible interval [95% CrI] = 1.25–10.11) and a 99.1% probability of increased odds. - New PPI initiation was not associated with a probable increase in CDI (aOR = 1.14; 95% CrI = 0.20–4.67). - Authors note the unexpected association and caution that results may be artefactual due to **confounding by indication**; they call for mechanistic and confirmatory studies. - The work is a preprint (not peer reviewed), funded by the Canadian Institutes of Health Research, with ethical approval from the McGill University Health Centre Research Ethics Board and trial registration NCT03272607. - Data are available on reasonable request. Two authors hold copyright to MedSafer in conjunction with McGill University.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Effect of Proton Pump Inhibitor Deprescription on the Risk of Clostridioides difficile Infection: A Quasi-Interventional Substudy of MedSafer Connor Prosty, Yohann Pilon, Jimin J Lee, Todd C Lee, Emily McDonald doi: https://doi.org/10.64898/2026.07.22.26358694 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Connor Prosty 1 McGill; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Connor%2BProsty%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Prosty%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AConnor%2BProsty%2B) * For correspondence: connor.prosty@mail.mcgill.ca Yohann Pilon 2 McGill University Health Centre; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yohann%2BPilon%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pilon%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYohann%2BPilon%2B) Jimin J Lee 2 McGill University Health Centre; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jimin%2BJ%2BLee%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lee%20JJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJimin%2BJ%2BLee%2B) Todd C Lee 3 McGill University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Todd%2BC%2BLee%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lee%20TC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATodd%2BC%2BLee%2B) Emily McDonald 4 Research Institute McGill University Health Centre * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emily%2BMcDonald%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=McDonald%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEmily%2BMcDonald%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1264842/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1264842/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1264842/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1264842/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1264842/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background Proton pump inhibitors (PPIs) have been proposed as a risk factor for initial and recurrent Clostridioides difficile infection (CDI) based on observational data. Whether desprescribing PPIs reduces the odds of incident CDI is unknown. Methods This was a secondary analysis of the cluster randomized MedSafer clinical trial dataset, in which hospitalized older adults taking five or more medications were randomized to usual care (a medication review) or electronic deprescribing decision support prior to hospital discharge. For this substudy, all patients were included regardless of trial assignment and were categorized according to their PPI use at hospitalization and discharge. The 30-day occurrence of CDI was compared as a function of PPI use using a Bayesian mixed-effect logistic regression adjusted for prespecified confounders. Results 4990 patients were included in the analysis, including 405 (8.1%) patients who were deprescribed their home PPI and 325 (6.5%) new PPI users. 30-day CDI occurred in 32 (0.6%) patients. PPI deprescription was associated with a 99.1% probability of increased odds of CDI (adjusted odds ratio[aOR]=3.66, 95%Credible interval[95%CrI]=1.25-10.11). New PPI use, however, was not associated with a probable increase in CDI (aOR=1.14, 95%CrI=0.20-4.67). Conclusion Unexpectedly, PPI deprescription was associated with a higher odds of CDI. This challenges the practice of deprescribing unnecessary PPIs in hospitalized patients for CDI prevention. However, it is possible this finding is artefactual due to confounding by indication. Further mechanistic and confirmatory studies are needed. ### Competing Interest Statement Drs. Lee and McDonald hold the copyright to MedSafer in conjunction with McGill University. ### Clinical Trial NCT03272607 (MedSafer trial) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Research Ethics Board at the Research Institute of the McGill University Health Centre gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared Canadian Institutes of Health Research, https://ror.org/01gavpb45 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.07.22.26358679v1 "Heterozygous germline MSH3 mutations, and probably MLH3 mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk")[Next ](https://www.medrxiv.org/content/10.64898/2026.07.22.26357171v1 "Understanding attrition: Feasibility and acceptability of a behavioral intervention for dementia care partners") Posted July 24, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/07/24/2026.07.22.26358694.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.07.22.26358694v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/07/24/2026.07.22.26358694.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Effect of Proton Pump Inhibitor Deprescription on the Risk of Clostridioides difficile Infection: A Quasi-Interventional Substudy of MedSafer Connor Prosty, Yohann Pilon, Jimin J Lee, Todd C Lee, Emily McDonald medRxiv 2026.07.22.26358694; doi: https://doi.org/10.64898/2026.07.22.26358694 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.22.26358694v1%26text%3DEffect%2520of%2520Proton%2520Pump%2520Inhibitor%2520Deprescription%2520on%2520the%2520Risk%2520of%2520Clostridioides%2520difficile%2520Infection%253A%2520A%2520Quasi-Interventional%2520Substudy%2520of%2520MedSafer "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.22.26358694v1%26t%3DEffect%2520of%2520Proton%2520Pump%2520Inhibitor%2520Deprescription%2520on%2520the%2520Risk%2520of%2520Clostridioides%2520difficile%2520Infection%253A%2520A%2520Quasi-Interventional%2520Substudy%2520of%2520MedSafer "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.22.26358694v1%26title%3DEffect%2520of%2520Proton%2520Pump%2520Inhibitor%2520Deprescription%2520on%2520the%2520Risk%2520of%2520Clostridioides%2520difficile%2520Infection%253A%2520A%2520Quasi-Interventional%2520Substudy%2520of%2520MedSafer%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.07.22.26358694v1%26title%3DEffect%2520of%2520Proton%2520Pump%2520Inhibitor%2520Deprescription%2520on%2520the%2520Risk%2520of%2520Clostridioides%2520difficile%2520Infection%253A%2520A%2520Quasi-Interventional%2520Substudy%2520of%2520MedSafer "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.07.22.26358694) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (590) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (883) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (320) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4652) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (464) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (399) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (628) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1582) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15585) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1164) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6855) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (707) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1027) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4820) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1404) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1681) * [Hematology](https://www.medrxiv.org/collection/hematology) (567) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1297) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16123) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1138) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (647) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (148) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (702) * [Neurology](https://www.medrxiv.org/collection/neurology) (6981) * [Nursing](https://www.medrxiv.org/collection/nursing) (357) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1052) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1200) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (983) * [Oncology](https://www.medrxiv.org/collection/oncology) (3489) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1011) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (381) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (430) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (450) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (135) * [Pathology](https://www.medrxiv.org/collection/pathology) (691) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1747) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (720) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (747) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5690) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9512) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2313) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1402) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1224) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (619) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (748) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (564) * [Surgery](https://www.medrxiv.org/collection/surgery) (748) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (105) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (295) * [Urology](https://www.medrxiv.org/collection/urology) (276) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [!
## Related Clinical Research

- [Spatial risk modeling forecasts US measles re-emergence and guides targeted vaccination](https://medichelpline.com/clinical-feed/medrxiv-8-epidemiologic-shifts-predict-spatial-patterns-of-measles-re-emergence-in-the.md)
- [Beyond conventional biomarkers: editorial on novel biomarkers and combinatorial approaches for imm](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-editorial-beyond-conventional-biomarkers-unlocking-immunotherapy-response.md)
- [Obesity-associated inflammation and cancer: mechanisms linking adipose immune changes to tumor risk](https://medichelpline.com/clinical-feed/frontiers-in-immunology-6-obesity-associated-inflammation-and-cancer-molecular-mechanisms-evidence-gaps.md)
- [Cannabidiol’s Effect on Auditory Mismatch Negativity in Children with Autism](https://medichelpline.com/clinical-feed/medrxiv-7-effects-of-cannabidiol-on-auditory-mismatch-negativity-in-autistic-children.md)
- [Could we one day vaccinate against every cancer? Latest on cancer vaccine trials and implications](https://medichelpline.com/clinical-feed/stat-news-3-could-we-one-day-vaccinate-against-every-cancer.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.